40
M. Pfeiffer et al. / Journal of Molecular Catalysis B: Enzymatic 110 (2014) 39–46
loop structures on the ␣/ core domain and on the CAP domain
[12]. Relationships between structure and specificity are only
weakly defined for HAD-like phosphatases. Substrate binding and
product release involve domain-closing and opening movements
of the CAP [9,13–15]. Protein conformational flexibility further
complicates efforts to infer substrate specificity from sequence
and three-dimensional structure information alone. Purposeful
alytic conversion of specific target substrates is therefore difficult.
development.
2.2. Expression and purification of His6 HAD4
Expression vector pCA24N-yihx encoding HAD4 equipped with
N-terminal hexahistidine tag was kindly provided by Dr. Alexan-
der Yakunin. The vector was transformed into electro-competent
cells of E. coli BL21 (DE3), and single-colony transformants were
selected on agar plates containing 0.025 mg/mL chloramphenicol.
Recombinant protein was produced in 1-L baffled shaking flasks
at 37 ◦C using an agitation rate of 110 rpm (Certomat BS-1 shaking
incubator, Sartorius, Göttingen, Germany). Flasks contained 250 mL
Lennox-medium supplemented with 0.025 mg/mL chlorampheni-
col. At OD600 of 0.8, temperature was decreased to 18 ◦C, 0.01 mM
isopropyl--d-thiogalactopyranoside (IPTG) was added, and culti-
vation was continued for 20 h. Centrifuged (4 ◦C, 30 min; 4,420 g)
and washed cells were suspended in 10 mL of 50 mM Mes pH
7.0 buffer and disrupted by triple passage through French pres-
sure cell at 150 bar (American Instruments, Silver Springs, USA).
After removal of cell debris (4 ◦C, 30 min; 20,000 g) and filtra-
tion through a 1.2 m cellulose-acetate syringe filter (Sartorius,
Göttingen, Germany). The pre-treated cell lysate (350 mg; 8 mL)
was loaded on a 14 mL copper-loaded affinity column (Chelating
Sepharose Fast Flow; XK 16/20 column, GE Healthcare, Little Chal-
font, U.K.), beforehand equilibrated with buffer A (50 mM Tris
HCl, pH 7.0 containing 300 mM NaCl) and mounted on an Bio-
Logic DuoFlowTM system (Biorad, Hercules, CA, USA). Differential
elution was performed with buffer B (50 mM Tris HCl, pH 7.0
containing 300 mM NaCl and 400 mM imidazole) at 10 ◦C and a
flow rate of 3 mL/min. The elution protocol comprised 5 steps,
whereas concentration of buffer B was stepwise increased to 0,
10, 30, 60 and 100% in a volume of 100, 90, 60, 30 and 75 mL,
respectively. All buffers were degassed and filtered using 0.45 m
cellulose-acetate or 0.2 m polyamide filters. Protein elution was
monitored spectrophotometrically at 280 nm, and collected frac-
tions were assayed for protein concentration and phosphatase
activity against p-nitrophenyl phosphate (pNPP; see Assays). Active
fractions were pooled and buffer was exchanged to buffer A2
(50 mM KH2PO4-buffer, pH 7.0) with Amicon Ultra-15 Centrifugal
Filter Units (Millipore, Billerica, USA). Pooled fractions were fur-
ther purified using a 50 mL Fractogel EMD-DEAE column (XK 26/20,
Merck, Darmstadt, Germany) mounted on a BioLogic DuoFlowTM
system. Protein elution was performed with buffer B2 (50 mM
KH2PO4, 1 M NaCl, pH 7.0) applying a five-step purification pro-
tocol at a constant flow rate of 5 mL/min: step 1, isocratic flow of
100% buffer A2 for 50 mL; step 2, linear increase to 15% buffer B2
in 40 mL; step 3, isocratic flow of 85% buffer A2 and 15% buffer
B2 for 80 mL; step 4, linear increase to 100% buffer B2 in 180 mL;
step 5, isocratic flow of 100% buffer B2 for 70 mL. Active fractions
were pooled and buffer was exchanged to 50 mM Hepes pH 7.0
with Amicon Ultra-15 Centrifugal Filter Units. Protein purification
was monitored by SDS PAGE and phosphatase activity measure-
ments.
Selectivity is a prime feature of many enzymatic transfor-
mations [16]. A growing number of examples show that in a
comparison of conventional-chemical and biocatalytic process
options in organic synthesis [17,18], it is usually the bio-based
selectivity that provides a decisive advantage for process develop-
ment. In this paper, we address the problem of substrate-selective
hydrolysis of ␣-d-glucose 1-phosphate (␣Glc 1-P) by phosphatases
and report identification of HAD4 (yihx gene product) from E. coli
for that purpose. Major demand for the reaction is in reactive
processing of mixtures of sugar phosphates to eliminate all of
the ␣Glc 1-P present in the starting material. Sample work-up
for analytics, in the field of sugar phosphate metabolomics for
example, and facilitated sugar phosphate product recovery con-
stitute interesting applications of selective ␣Glc 1-P converting
phosphatases. The readily available broad-spectrum phosphatases
are however not suitable for these applications, and discovery
of new phosphatase catalysts is therefore required. HAD4 was
obtained as highly active recombinant enzyme through a specially
designed fusion protein (Zbasic2 HAD4) that contained Zbasic2, a
strongly positively charged three ␣-helical bundle module, at its
N-terminus [19]. Zbasic2 facilitated functional expression of solu-
ble protein in E. coli and enabled protein capture and polishing
efficiently combined in a single step of cation exchange chromatog-
raphy. Furthermore, the Zbasic2 module had an instrumental role
in the development of an immobilized HAD4 biocatalyst where
Zbasic2 HAD4 was bound directly from crude bacterial cell extract
on sulfonic acid group-containing porous carriers. Attachment of
fusion protein to the negatively charged carrier surface was not only
highly selective in that accompanying E. coli protein only showed
marginal binding under the conditions used, but it also appeared
to have occurred in a strongly preferred orientation via the cationic
binding module: immobilized Zbasic2 HAD4 was nearly as effec-
tive as the free enzyme. Kinetic characterization of Zbasic2 HAD4
with ␣Glc 1-P and the competing sugar phosphate substrate d-
glucose 6-phosphate (Glc 6-P) is reported. Utilization of different
sugar phosphates as substrates for hydrolysis by Zbasic2 HAD4 is
described, and some basic properties of the enzyme fused to Zbasic2
are reported. Clear-cut separation of Glc 6-P from ␣Glc 1-P through
selective hydrolysis of the sugar 1-phosphate at high concentra-
tion (up to 180 mM) and in the presence of up to 9-fold excess of
competing substrate is shown.
Alternatively, the pre-treated cell lysate (280 mg; 8 mL) was
loaded on 1.6 cm × 2.5 cm; 5 mL HisTrap FF column (GE Health-
care), equilibrated with buffer C (50 mM MES, pH 7.4 containing
125 mM NaCl, 20 mM imidazole) and mounted on an ÄKTA prime
plus (GE Healthcare) system. Protein was eluted using an imid-
azole gradient from 0 to 80% buffer D (50 mM MES, pH 7.4
containing 125 mM NaCl and 500 mM imidazole) at 10 ◦C and
at a flow rate of 4 mL/min. At 20% buffer D, the linear gradient
was halted for 2 column volumes to facilitate differential elu-
tion of bound protein. Active fractions were pooled and buffer
was exchanged to 50 mM MES, pH 7.0. Protein purification was
monitored by SDS PAGE and phosphatase activity measurements.
Densitometry evaluation of the SDS PAGE was performed with
2. Materials and methods
2.1. Chemicals and reagents
Unless stated otherwise, all chemicals were of highest purity
available from Sigma–Aldrich (Vienna, Austria) or Roth (Karlsruhe,
Germany). Sugar phosphates were obtained as sodium or ammo-
nium salts. Oligonucleotide primers were from Sigma–Aldrich
(Vienna, Austria). DNA sequencing was done at LGC Genomics
(Berlin, Germany).